BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
T cell receptor signaling pathway
,
Leukemia
,
Adipose tissue
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Phospholipase D-like domain
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Lung
Stomach pyloric
Thyroid gland
Pericardium
Prostate gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Multiple-resistant Staphylococcus aureus infection
Hemorrhagic shock
Heart valve disorder
Epithelial hyperplasia of skin
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Chlorzoxazone
C-Peptide
rifapentine
penciclovir
Prnp protein, mouse
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Notch1
SPEN
TRAF2
mmu-miR-155-5p
NEUROD2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Pulmonary endothelial cells after monocrotaline treatment
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
Buffering and proteolysis are induced upon segmental haploidy in D. melanogaster
Hepatitis C virus-induced gene expression in Huh7 host cells 6-48hr after infection
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Phospholipase D-like domain
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patien…
Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeuti…
Study on Metabolic Flexibility and Gut Microbiota Composition in Obese Subjects With NAFLD, Taking I…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ